Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16694058 | 0.80 | L3MBTL1 (0.34) | KMT2AALDH1A1 | |
| SCHEMBL28124929 | 0.75 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6559923 | 0.75 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28330537 | 0.75 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL303034 | 0.74 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28082107 | 0.74 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27904863 | 0.74 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1270421 | 0.74 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| Phosphine SCHEMBL21980905 | 0.74 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27584937 | 0.74 | CA12 (0.44) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115820187-A | High-cohesiveness ultraviolet-curing adhesive and preparation method thereof | 广东光固新材料有限公司 | 2023-03-21 | — | — | CN | claimed |
| EP-3200754-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2017-08-09 | — | — | EP | claimed |
| US-20170209360-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2017-07-27 | — | — | US | claimed |
| WO-2016050793-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | L'OREAL (FR) | 2016-04-07 | — | — | WO | claimed |
| EP-2417210-B1 | CURABLE ADHESIVE COMPOSITIONS | PIXELOPTICS INC (US) | 2013-03-06 | — | — | EP | claimed |
| EP-1373980-B1 | HIGH PERFORMANCE, PHOTOIMAGEABLE RESIN COMPOSITIONS AND PRINTING PLATES PREPARED THEREFROM | NAPP SYSTEMS INC (US) | 2012-05-09 | — | — | EP | claimed |
| EP-2417210-A1 | CURABLE ADHESIVE COMPOSITIONS | Pixeloptics Inc. (US) | 2012-02-15 | — | — | EP | claimed |
| WO-2010118421-A1 | CURABLE ADHESIVE COMPOSITIONS | PIXELOPTICS, INC. (US) | 2010-10-14 | — | — | WO | claimed |
| US-20100261018-A1 | Curable Adhesive Compositions | PIXELOPTICS, INC. (US) | 2010-10-14 | — | — | US | claimed |
| EP-2206002-A1 | DIFFRACTIVE OPTICAL ELEMENT AND USE OF AN OPTICAL ADHESIVE FOR PRODUCING THE SAME | Carl Zeiss AG (DE) | 2010-07-14 | — | — | EP | claimed |
| WO-2009056196-A1 | DIFFRACTIVE OPTICAL ELEMENT AND USE OF AN OPTICAL ADHESIVE FOR PRODUCING THE SAME | CARL ZEISS AG (DE) | 2009-05-07 | — | — | WO | claimed |
| EP-1440097-B1 | HIGH INDEX CURABLE PHOTOCHROMIC COMPOSITION AND ITS PROCESS | RODENSTOCK GMBH (DE) | 2008-03-12 | — | — | EP | claimed |
| US-6583195-B2 | Having deeper penetration due to transport structure of sealer | BOND DISTRIBUTING, LTD. | 2003-06-24 | — | — | US | claimed |
| US-20030008934-A1 | For sealing and priming sheet molded compound for use in automotive body panel | UV COATINGS, LTD. | 2003-01-09 | — | — | US | claimed |
| EP-3518863-B1 | DENTAL COMPOSITION | DENTSPLY DETREY GMBH (DE) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023203869-A1 | PHOTOREACTIVE ORGANOPOLYSILOXANE, METHOD FOR PRODUCING SAME, AND PHOTOCURABLE COMPOSITION | 信越化学工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| WO-2023105906-A1 | REINFORCEMENT FILM | 日東電工株式会社 | 2023-06-15 | — | — | WO | disclosed |
| WO-1998033855-A1 | RADIATION-CURABLE COMPOSITION | DSM N.V. (NL) | 1998-08-06 | — | — | WO | disclosed |
| EP-0830928-A2 | Resin composition and mold made from such resin, for forming fibrous material | DSM N.V. (NL) | 1998-03-25 | — | — | EP | disclosed |
| WO-1997044399-A1 | RADIATION CURABLE BINDER COMPOSITION | DSM N.V. (NL) | 1997-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170209360-A1 | COSMETIC PROCESS FOR ATTENUATING WRINKLES | CUTA, MC1R, GLA | CA12 4066/4885CA1 4861/4885CA2 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.